ED Pharma

What ED Pharma does

ED Pharma is a privately held Egyptian pharmaceutical manufacturer headquartered in Gamasa, Dakahlia, in Egypt's Delta zone, with sales offices in Cairo and an administration office in Mansoura. The company operates a 3,000 square meter GMP-compliant manufacturing facility structured across three buildings: a 350 sqm administration and laboratory building, a 1,250 sqm general factory for liquid, solid, and sterile dosage forms including vials and ampoules, and a 445 sqm dedicated cephalosporins facility maintained as a separate production area for worker safety. The company claims to operate the first general sterile production lines and the first cephalosporins manufacturing facility in the Delta zone.

The company manufactures four product categories: human pharmaceuticals, dietary supplements, cosmetics, and veterinary pharmaceuticals spanning equine, pet, aquaculture, feed additive, and disinfectant segments. It also offers pharmacovigilance services and contract/toll manufacturing for third parties. ED Pharma employs a B2B, sales-led distribution model targeting pharmaceutical distributors, healthcare professionals, and end users, with claimed global distribution reach and a stated public vision to become the leading Middle East pharmaceutical manufacturer by 2027.

The company has approximately 39 employees, no disclosed revenue, no disclosed funding history, no institutional ownership, and no disclosed leadership team beyond functional company descriptions. Pricing is not publicly disclosed, and revenue mechanics appear to derive from one-time product sales across the four categories plus toll manufacturing service fees.

Name

ED Pharma

Legal name

ED Pharma

Website

https://edpharma.com.eg

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

ED Pharma is a privately held Egyptian pharmaceutical manufacturer operating a 3,000 sqm GMP-compliant facility in Gamasa, Dakahlia, producing human pharmaceuticals, supplements, cosmetics, and veterinary products, plus toll manufacturing and pharmacovigilance services for distributors and healthcare professionals.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

akta.pro secondary industries

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

Keywords

• Pharmaceutical manufacturing
• Sterile injectables
• Cephalosporins production
• Veterinary pharmaceuticals
• GMP contract manufacturing

Headquarters

HQ city

Cairo

HQ country

Egypt

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Sale of pharmaceutical products including human medicines
2. Supplements: Sale of dietary and health supplements
3. Cosmetics: Sale of cosmetic products
4. Veterinary Products: Sale of veterinary pharmaceutical products including equine, pets, aquaculture, feed additives, and disinfectants

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

ED Pharma manufactures and sells human pharmaceuticals, dietary supplements, cosmetics, and veterinary products (covering equine, pets, aquaculture, feed additives, and disinfectants) from its GMP-compliant factory in Gamasa, Egypt. It also offers toll/contract pharmaceutical manufacturing and pharmacovigilance services, leveraging general sterile production lines (vials and ampoules) and a dedicated cephalosporins facility.

Product overview

ED Pharma is a manufacturing pharmaceutical company based in Egypt operating a multi-product portfolio. The company produces four main product categories: Pharmaceuticals (human medicine), Supplements, Cosmetics, and Veterinary Products. The Veterinary division encompasses sub-segments for Pharmaceuticals (equine, pets), Disinfectants, Aquaculture treatments, and Feed Additives. ED Pharma operates its own GMP-compliant manufacturing facility in the Delta zone of Egypt, spanning 3000 square meters across three buildings, producing liquid dosage forms (vials, bottles, sachets), solid dosage forms (tablets, capsules, powders), and sterile dosage forms, including a dedicated cephalosporins building.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceuticals

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• EVA Pharma: Major Egyptian pharmaceutical manufacturer with a broad portfolio across human generics, sterile injectables, and cephalosporins, also serving regional MENA markets. Competes head-to-head with ED Pharma for distributor relationships and tenders in Egypt and the wider region.
• EIPICO (Egyptian International Pharmaceutical Industries Company): One of Egypt's largest pharmaceutical manufacturers, producing a wide range of human generics, cephalosporins, and sterile injectables. Directly comparable to ED Pharma as a domestic Egyptian manufacturer competing for the same B2B distributor and healthcare professional channels.
• Pharco Pharmaceuticals: One of Egypt's largest pharmaceutical groups, manufacturing generics, sterile products, and cephalosporins with extensive domestic and regional distribution. Closely comparable to ED Pharma in product categories and customer base, though at substantially larger scale.
• Amoun Pharmaceutical: Egyptian pharma manufacturer producing human medicines across multiple therapeutic categories. Now part of the larger Eva group, Amoun is a direct comparable to ED Pharma in serving the same domestic distributor network with similar product types.
• Minapharm Pharmaceuticals: Egypt-based pharmaceutical manufacturer with capabilities in sterile injectables and biopharmaceuticals, serving regional and European markets. Comparable to ED Pharma in sterile manufacturing focus and geographic positioning, though with stronger export penetration.
• EGYPharma (Egyptian Generic Pharmaceutical Industries): Egyptian pharmaceutical manufacturer focused on generics and sterile dosage forms for local and regional markets. Comparable to ED Pharma as a domestic Egyptian manufacturer with overlapping sterile injectable capabilities and similar B2B distributor-led go-to-market.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer serving the wider MENA region with a broad human generics and sterile injectables portfolio. Comparable to ED Pharma's vision of MENA leadership, providing a regional benchmark for scale-up trajectory though operating from a different geography.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Leading Saudi pharmaceutical manufacturer with a broad human generics portfolio including sterile and cephalosporin products. Comparable to ED Pharma's product categories and regional MENA ambition, though a substantially larger publicly listed entity.
• Jazeera Pharmaceutical Industries (JPI): Saudi-based pharmaceutical manufacturer producing generics, sterile injectables, and cephalosporins across multiple dosage forms. Comparable to ED Pharma in cephalosporins and sterile manufacturing focus, though operating primarily in Saudi Arabia rather than Egypt.

Broad incumbents

• Cipla Limited: Global pharmaceutical major with a strong emerging-markets franchise in generics, sterile injectables, cephalosporins, and veterinary products. Comparable to ED Pharma across multiple product categories, though operating at vastly greater scale and as a broad incumbent rather than a regional specialist.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/edpharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ED Pharma